Tackling the Global Blood Shortage Crisis: Heme Solutions Introduces the MDXViewer. MDX LIFESCIENCES holds a distinctive FDA clearance for a device that monitors NADH levels in patients.

Heme Solutions is proud to announce a revolutionary new product in partnership with MDX Lifesciences — the MDXViewer. In response to the growing global blood shortage crisis, the MDXViewer is a cutting-edge, first-generation monitoring system designed to optimize blood management and provide deeper insights into patient health. By combining advanced real-time tissue-level analysis with systemic vital signs, the MDXViewer is poised to play a crucial role in addressing blood shortages while enhancing patient care worldwide.

The Blood Shortage Crisis: A Global Challenge

The world is facing a significant and persistent shortage of blood donations, which impacts millions of patients each year. From accident victims to those undergoing surgeries, cancer treatments, and patients with chronic blood conditions, the demand for blood is constantly high. According to the World Health Organization (WHO), there is a global need for approximately 118 million blood donations every year, but many countries struggle to meet this demand.

In response to this challenge, Heme Solutions has partnered with MDX Lifesciences to create a solution that could revolutionize blood management in hospitals and healthcare systems worldwide. The MDXViewer is not just a product — it is a step toward revolutionizing healthcare practices and providing an innovative way to monitor patients’ blood health and vital signs, reducing the reliance on blood transfusions and improving overall patient outcomes.

The Power of the MDXViewer: Real-Time Monitoring for Smarter Blood Management

The MDXViewer is a first-generation product created and manufactured by MDX Lifesciences, designed to monitor and analyze a patient’s physiological activities in real-time. The device offers a comprehensive and non-invasive solution by integrating tissue-level metabolic monitoring with systemic vital signs. This combined approach allows healthcare professionals to gain a holistic view of a patient’s health, providing insights into both the macro (systemic) and micro (tissue-level) aspects of the body’s functions.

Tissue-Level Analysis and Systemic Vital Signs: A Complete Monitoring Solution

What sets the MDXViewer apart is its ability to monitor both tissue-level activities and systemic vital signs simultaneously. Traditionally, healthcare devices focus on either general vital signs or metabolic activity within tissues, but the MDXViewer brings both together in a seamless way:

Tissue-Level Analysis: The MDXViewer allows clinicians to monitor metabolic activities at the tissue level, providing insights into how well organs and cells are functioning. This is especially important in assessing how blood is circulating through tissues, how tissues are metabolizing nutrients, and how well they are healing or regenerating after injury.
Systemic Vital Signs: Alongside tissue-level analysis, the device continuously tracks systemic vital signs like heart rate, blood pressure, respiratory rate, and oxygen saturation. This enables clinicians to assess the overall health of a patient and understand how their blood circulation is supporting systemic functions.

Revolutionizing Blood Management with NADH Monitoring

One of the most groundbreaking features of the MDXViewer is its ability to monitor NADH (Nicotinamide Adenine Dinucleotide Hydride) levels in patients. NADH is a crucial coenzyme involved in cellular energy production and metabolic processes, and its levels can provide essential insights into a patient’s cellular health, metabolic function, and overall tissue viability.

MDX Lifesciences is proud to hold unique FDA clearance for a device that can monitor NADH levels in patients. This approval places the MDXViewer in a league of its own and makes it the first FDA-cleared device capable of monitoring NADH in real time. By continuously

tracking NADH, clinicians can detect early signs of metabolic dysfunction, tissue hypoxia, and insufficient oxygenation, all of which are critical factors in blood health and transfusion needs.

How NADH Monitoring Helps Combat Blood Shortages

Understanding the role of NADH in blood and tissue health is crucial to reducing the need for blood transfusions and improving patient care. By monitoring NADH levels in real time, the MDXViewer allows healthcare professionals to:

Optimize Blood Use: By assessing the metabolic status of a patient’s tissues, clinicians can determine whether a blood transfusion is truly necessary or if there are other interventions (such as improving oxygenation or supporting metabolic activity) that could reduce the need for donated blood.
Improve Recovery: The MDXViewer can track how effectively the body is regenerating blood and tissues, especially after surgery or trauma. By monitoring NADH levels, healthcare providers can gain insights into whether a patient’s body is sufficiently prepared to regenerate healthy blood cells, reducing the dependency on external blood supplies.
Personalized Care: Each patient is different, and blood management should be tailored to individual needs. The MDXViewer allows for personalized care plans by offering detailed, real-time insights into metabolic function, reducing the guesswork and providing a clearer path to optimal patient recovery.

A Holistic Approach to Healthcare

The MDXViewer offers a comprehensive view of a patient’s health by monitoring both metabolic activities at the tissue level and systemic vital signs. This combination provides clinicians with a more detailed and holistic understanding of a patient’s condition, leading to:

Better Early Detection: With real-time monitoring, potential complications, including blood-related issues, can be detected earlier, allowing for timely intervention.
Smarter Decision Making: The integration of NADH monitoring with traditional vital signs means that healthcare providers can make more informed decisions regarding blood management and other critical care interventions.
Non-Invasive and Continuous Monitoring: The MDXViewer offers non-invasive, continuous monitoring, eliminating the need for painful procedures or frequent blood draws, while providing valuable insights into a patient’s blood and metabolic health.

The Future of Blood Management

The MDXViewer is a first-generation product, but its potential to change the landscape of healthcare is immense. As blood shortages continue to be a global concern, solutions like the MDXViewer can play a crucial role in optimizing the use of donated blood and improving patient outcomes. By enhancing the way blood health and tissue function are monitored, the MDXViewer offers hope for a future where blood shortages are less of a crisis and more of a manageable challenge.

Conclusion: A Step Toward Smarter, More Efficient Healthcare

The MDXViewer represents a revolutionary advancement in the field of healthcare, particularly in tackling the global blood shortage issue. Through real-time monitoring of tissue-level activities and systemic vital signs, coupled with the groundbreaking ability to monitor NADH levels, this innovative device provides healthcare professionals with an unprecedented view of patient health.

By reducing reliance on blood transfusions, improving patient recovery, and enabling smarter, more personalized care, the MDXViewer offers a new paradigm in blood management. Heme Solutions, in collaboration with MDX Lifesciences, is committed to driving innovation and supporting healthcare systems around the world in their efforts to meet the growing demand for blood while enhancing overall patient care.

Stay tuned for more updates on how the MDXViewer is changing the face of healthcare and blood management worldwide.